IP Library Granted Patent US 10,894,953
Granted Patent B2
US 10,894,953 · App. 15/873,977 · Granted Jan 19, 2021

Enzyme variants with improved ester synthase properties

Inventors: Andrew M. Shumaker (South San Francisco, CA); Bernardo M. da Costa (South San Francisco, CA); Kevin Holden (South San Francisco, CA); Louis G. Hom (South San Francisco, CA); Tarah S. Baron (South San Francisco, CA); Noah Helman (South San Francisco, CA)
Assignee: Genomatica, Inc.
C12N9/18C12N9/1007C12P7/6436C12Y201/01015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,894,953
App. No.
15/873,977
Granted
Jan 19, 2021
Kind
B2
Abstract

The disclosure relates to enzyme variants with improved ester synthase properties for the production of fatty acid esters. Further contemplated are recombinant host cells that express such variants, cell cultures comprising the recombinant host cells and fatty acid ester compositions produced by such recombinant host cells.

Claims (1)

1. A variant ester synthase polypeptide comprising a variant of SEQ ID NO: 67, wherein said variant ester synthase polypeptide the variant of SEQ ID NO: 67 is genetically engineered to have at least one substitution mutation at an amino acid position selected from the group of G4R, T5P, T5S, D7N, S15G, T24M, T24W, L30H, G33S, L39A, L39M, L39S, R40S, D41A, D41G, D41H, D41Y, V43K, V43S, T44F, A73Q, V76L, D77A, K78F, K78W, I80V, R98D, E99Q, G101L, I102R, P111D, P111G, P111S, H122S, R131M, I146K, I146L, I146R, S147A, V149L, R150P, V155G, N164R, P166S, T170R, V171E, V171F, V171H, V171R, V171W, R172S, R172W, P173W, R177V, A179V, D182G, E184F, E184G, E184L, E184R, E184S, A185L, A185M, S186T, V187G, V187R, P188R, A190P, A190R, A190W, S192A, S192L, S192V, Q193R, Q193S, M195G, A197T, A197V, Q201A, Q201V, Q201W, A202L, D203R, P206F, R207A, G212A, G212L, V219L, V234C, H239G, T242K, T242R, A243R, Q244G, R246A, R246G, R246L, R246Q, R246V, R246W, K258R, S264D, S264V, S264W, S267G, A285R, P294G, V301A, N302G, I303G, I303R, I303W, R304W, A306G, D307F, D307G, D307L, D307N, D307R, D307V, E309A, E309G, E309S, G310H, G310R, G310V, T311S, T313S, Q314G, I315F, S316G, F317W, I319G, A320C, A323G, D328F, Q334S, Q348A, Q348R, K349A, K349C, K349H, K349Q, P351G, K352I, K352N, S353T, T356G, T356W, Q357V, M360Q, M360R, M360S, M360W, Y366G, Y366W, G375A, G375V, G375S, V381F, E393R, E393W, T395E, V409L, L411A, I420V, S424G, S424Q, S442E, S442G, M443G, A447C, A447I, A447L, L454V, D455E, L457Y, E458W, I461G, K466N, A468G, K472T and K472*, wherein said variant ester synthase polypeptide has improved fatty acid ester activity compared to a corresponding wild type polypeptide comprising the amino acid sequence of SEQ ID NO: 67.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
Continuity (4)
Continuation 14424387
Provisional Application 61701191 · Sep 14, 2012
Provisional Application 61708424 · Oct 1, 2012
Related Publication 20180327728A1 · Nov 15, 2018
Cited By (1)
US 12,398,383